Matthew Hickman
University of Bristol
227 Papers
1.1K Citations
Matthew Hickman is an academic researcher from University of Bristol. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 45, co-authored 226 publications. Previous affiliations of Matthew Hickman include National Institute for Health Research & University Hospitals Bristol NHS Foundation Trust.
Chat about Author
Papers
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
Graham S Cooke,Isabelle Andrieux-Meyer,Tanya L. Applegate,Rifat Atun,Jessica R Burry,Hugo Cheinquer,G.M. Dusheiko,Jordan J. Feld,Charles Gore,Max Griswold,Saeed Hamid,Margaret Hellard,Jinlin Hou,J. Howell,Jidong Jia,Natalia Kravchenko,Jeffrey V. Lazarus,Maud Lemoine,Olufunmilayo A. Lesi,Liudmyla Maistat,Brian J. McMahon,Homie Razavi,Teri Roberts,Bryony Simmons,Mark W. Sonderup,C Wendy Spearman,Bridie E Taylor,David L. Thomas,Imam Waked,John W. Ward,Stefan Wiktor,Ayman Abdo,Rakesh Aggarwal,Alessio Aghemo,Bandar Al-Judaibi,Mamun Al Mahtab,Arshad Altaf,Zyaad Ameen,Tarik Asselah,Oidov Baatarkkhuu,Ella Barber,Eleanor Barnes,Pascale Boulet,Louise Burrows,Maia Butsashvili,Erica Chan,Chelsea Chow,Ben Cowie,Chris Cunningham,Alexandre de Araujo,Graciela Diap,G.J. Dore,Joseph Doyle,Manal Elsayed,Emmanuel Fajardo,Edward Gane,Aneley Getahun,David J. Goldberg,Tiffany Got,Matthew Hickman,Andrew F. Hill,Sharon J. Hutchinson,Christopher R. Jones,Saleem Kamili,Amreen Khan,Alice Lee,Tin Yan Lee,Jioiji Malani,Tammy Meyers Morris,Shevanthi Nayagam,Richard Njouom,Ponsiano Ocama,Alisa Pedrana,Rosanna W. Peeling,Amulya Reddy,Jilian A. Sacks,Shiv Kumar Sarin,Yusuke Shimakawa,Marcela Silva,Pavlo Skala,Simon D. Taylor-Robinson,Alexander J. Thompson,Mark Thursz,Alfred Tonganibeia,Jack Wallace,James Ward,Fernando Herz Wolff,Peter Vickerman,Johnny Yau +88 more
TL;DR: Key recommendations include a greater focus on national progress towards elimination with support given, if necessary, through innovative financing measures to ensure elimination programmes are fully funded by 2020.
510
Mental health before and during the COVID-19 pandemic in two longitudinal UK population cohorts.
Alex S. F. Kwong,Rebecca M. Pearson,Mark Adams,Kate Northstone,Kate Tilling,Daniel J. Smith,Chloe Fawns-Ritchie,Helen Bould,Naomi Warne,Stanley Zammit,David Gunnell,Paul Moran,Nadia Micali,Abraham Reichenberg,Matthew Hickman,Dheeraj Rai,Simon Haworth,Archie Campbell,Drew Altschul,Robin Flaig,Andrew M. McIntosh,Debbie A Lawlor,David J. Porteous,Nicholas J. Timpson +23 more
TL;DR: In both studies, anxiety and depression during the pandemic was greater in younger members, women, those with pre-existing mental/physical health conditions and individuals in socioeconomic adversity, even when controlling for pre-pandemicxiety and depression.
Opioid use disorder.
John Strang,John Strang,Nora D. Volkow,Louisa Degenhardt,Matthew Hickman,Kimberly Johnson,George F. Koob,Brandon D.L. Marshall,Mark W. Tyndall,Sharon L. Walsh +9 more
- 09 Jan 2020
TL;DR: The risk factors of opioid use disorder, together with its epidemiology, mechanisms, diagnosis and treatment, are discussed, including community preventive strategies, harm reduction interventions to reduce adverse sequelae from ongoing use and mutual aid groups.
425
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis.
Thomas Santo,Brodie Clark,Matthew Hickman,Jason Grebely,Gabrielle Campbell,Gabrielle Campbell,Luis Sordo,Aileen Chen,Aileen Chen,Lucy Thi Tran,Chrianna Bharat,Prianka Padmanathan,Gráinne Cousins,Julie Dupouy,Erin Kelty,Roberto Muga,Bohdan Nosyk,Bohdan Nosyk,Jeong Min,Raimondo Maria Pavarin,Michael Farrell,Louisa Degenhardt +21 more
TL;DR: In this article, a systematic review and meta-analysis on the relationship between Opioid agonist treatment (OAT) and specific causes of mortality was conducted. But the authors did not find a significant association between time receiving OAT and mortality.
362
Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
Norah Palmateer,Jo Kimber,Jo Kimber,Matthew Hickman,Sharon J. Hutchinson,Tim Rhodes,David J. Goldberg +6 more
TL;DR: The evidence is weaker than given credit for in the literature and the lack of evidence for effectiveness of NSP vis-à-vis biological outcomes (HCV and HIV incidence/prevalence) reflects the limitations of studies that have been undertaken to investigate these associations.